Clinical Trials Logo

Filter by:
NCT ID: NCT03873961 Recruiting - Plantar Fascitis Clinical Trials

Effect of HILT vs LLLT in Treatment of Patients With Achilles Tendinitis or Plantar Fasciitis

Start date: January 3, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate and compare the changes of heel pain, functional health and well-being after high-intensity and low-level laser therapy for plantar fasciitis or Achilles tendinopathy

NCT ID: NCT03869892 Not yet recruiting - Clinical trials for Metastatic Colorectal Cancer

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

SOLSTICE
Start date: March 20, 2019
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bevacizumab.

NCT ID: NCT03866304 Recruiting - Tattoo Removal Clinical Trials

Performance Evaluation of Tattoo Removal

Start date: January 21, 2019
Phase: N/A
Study type: Interventional

Evaluate safety and efficacy of S2 multi-wavelength laser for tattoo removal

NCT ID: NCT03851367 Completed - Clinical trials for Juvenile Osteochondrosis of Spine

Sling Suspension Versus Gym Balls in the Treatment of Juvenile Spinal Osteochondrosis

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study compares effect of swiss ball exercises with sling suspension exercises in the treatment of juvenile osteochondrosis in adolescent-girls

NCT ID: NCT03820713 Recruiting - Clinical trials for Reduction of Postoperative Adhesions

Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System

Start date: May 9, 2018
Phase: N/A
Study type: Interventional

Evaluation of the feasibility, safety, initial efficacy and usability of FuseX Anti-Adhesion system toward further studies that will be powered to proved its safety and efficacy. In addition, this initial study will serve to yield blood bank and surgeon feedback towards improving the system.

NCT ID: NCT03812328 Recruiting - Clinical trials for Venous Thromboembolism

Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement

COURSE
Start date: February 20, 2019
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to determine if an investigational medication called SelK2 works in preventing a condition called "venous thromboembolism" (VTE) in patients having a total knee replacement. SelK2 has been designed to attach to a protein found on blood cells and blood vessels. By attaching to this protein, SelK2 is designed to decrease the inflammatory process in the blood vessel wall that leads to the formation of blood clots in the vessel (called thrombosis). By decreasing the inflammatory process, SelK2 may reduce the risk of VTE following joint replacement surgery. In addition, because SelK2 is not a blood thinner, it is expected that the risk for bleeding will also be reduced.

NCT ID: NCT03807674 Completed - Pulpitis Clinical Trials

MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis

Start date: March 27, 2017
Phase: N/A
Study type: Interventional

Matrix metallopeptidase-9 (MMP-9) expression was compared in healthy and inflamed pulp and the outcome of coronal pulpotomy in teeth with symptomatic pulpitis was assessed. After procedure blood samples were examined using Elisa kit.

NCT ID: NCT03805100 Not yet recruiting - Clinical trials for Macular Degeneration

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

XPLORE
Start date: March 2019
Phase: Phase 3
Study type: Interventional

The objectives of this study are to demonstrate the equivalence of Xlucane to Lucentis® in treatment of subjects with wet (ie, neovascular) age-related macular degeneration (wAMD).

NCT ID: NCT03804580 Recruiting - Lung Cancer Clinical Trials

First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies

FIOL
Start date: December 1, 2018
Phase: Phase 2
Study type: Interventional

Phase II, single-arm study to assess the safety and efficacy of osimertinib (80 mg, orally, once daily) as first-line therapy in patients with EGFR mutation-positive, locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously treated with an epidermal growth factor tyrosine kinase inhibitor agent.

NCT ID: NCT03796702 Terminated - Clinical trials for Ileostomy, Rectal Cancer

Early Versus Late Closure of Preventive Ileostomy

Start date: November 1, 2011
Phase: N/A
Study type: Interventional

The study is designed and performed as a prospective randomized controlled single-center study. Patients who underwent rectal resection with preventive ileostomy due to rectal cancer will be included. The study investigates the effect of reversing a temporary ileostomy after 30 vs 90 days.